Acetylcysteine
Acetylcysteine is a pharmaceutical drug with 35 clinical trials. Currently 1 active trials ongoing. Historical success rate of 79.2%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
9
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
73.1%
19 of 26 finished
26.9%
7 ended early
1
trials recruiting
35
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke
Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
Clinical Trials (35)
Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke
Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold
Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
Effect of N-Acetylcysteine on Autologous Fat Graft Survival
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei
Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease
Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis
Outcomes of Patients After Allo-HSCT With Decitabine and NAC
The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
PP100-01 (Calmangafodipir) for Overdose of Paracetamol
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical Ventilation
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation
Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 35